BAUSCH HEALTH AMERICAS, INC.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Employees
- 3.1K
- Market Cap
- -
- Website
- http://www.bauschhealth.com
Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
Phase 4
Completed
- Conditions
- Opioid-Induced Constipation
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 237
- Registration Number
- NCT00672477
- Locations
- π¬π§
Salix Investigational Site, Cheltenham, Gloucestershire, United Kingdom
π²π½Pfizer Investigational Site, Mexico City DF, Mexico
Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures
Phase 2
Completed
- Conditions
- Opioid-induced Constipation
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT00640146
- Locations
- πΊπΈ
Progenics Pharmaceuticals, Inc, Tarrytown, New York, United States
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
- Conditions
- Parkinson Disease
- First Posted Date
- 2008-02-27
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bausch Health Americas, Inc.
- Registration Number
- NCT00624741
PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00622375
Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 187
- Registration Number
- NCT00612105
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
Not Applicable
Completed
- Conditions
- Fecal Incontinence
- Interventions
- Device: Sham InjectionDevice: NASHA/Dx (Solesta) Gel
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 206
- Registration Number
- NCT00605826
- Locations
- πΊπΈ
Colon & Rectal Surgery Associates, Minneapolis, Minnesota, United States
πΊπΈUniversity of California, San Francisco, Center for Pelvic Physiology, Dept. of Surgery, San Francisco, California, United States
πΊπΈLahey Clinic, Department of Colon & Rectal Surgery, Burlington, Massachusetts, United States
Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT00605644
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 8000
- Registration Number
- NCT00568997
- Locations
- πΊπΈ
Registry, Philadelphia, Pennsylvania, United States
Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
Phase 3
Completed
- Conditions
- HIV Associated Diarrhea
- Interventions
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 374
- Registration Number
- NCT00547898
Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain
Phase 2
Completed
- Conditions
- Constipation
- Interventions
- Other: placeboDrug: N-methylnaltrexone bromide (MOA-728)
- First Posted Date
- 2007-10-22
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT00547586
Β© Copyright 2025. All Rights Reserved by MedPath